IRWD icon

Ironwood Pharmaceuticals

227 hedge funds and large institutions have $1.12B invested in Ironwood Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 93 increasing their positions, 80 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

26% less capital invested

Capital invested by funds: $1.5B → $1.12B (-$383M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

59% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 51

Holders
227
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$73.6M
Puts
$186K
Net Calls
Net Calls Change

Top Buyers

1 +$15.6M
2 +$14.2M
3 +$13.3M
4
Pacer Advisors
Pacer Advisors
Pennsylvania
+$11.1M
5
Renaissance Technologies
Renaissance Technologies
New York
+$9.6M

Top Sellers

1 -$30.5M
2 -$9.02M
3 -$8.35M
4
UBS Group
UBS Group
Switzerland
-$7.75M
5
SSA
Schonfeld Strategic Advisors
New York
-$6.29M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$884K
77
$845K
78
$808K
79
$777K
80
$773K
81
$757K
82
$755K
83
$730K
84
$721K
85
$714K
86
$711K
87
$688K
88
$677K
89
$670K
90
$664K
91
$662K
92
$618K
93
$606K
94
$586K
95
$557K
96
$546K
97
$535K
98
$535K
99
$534K
100
$528K